+44-74-1148-3554 
Opinion Article - American Journal of Physiology, Biochemistry and Pharmacology (2023)
Mechanisms of Anticonvulsants in Seizure Treatment
Aliena Desuja*Aliena Desuja, Department of Pharmacology, University of Rajshahi, Rajshahi, Bangladesh, Email: desuja_a65@gmail.com
Received: 27-Jun-2023, Manuscript No. AJPBP-23-109519; Editor assigned: 30-Jun-2023, Pre QC No. AJPBP-23-109519(PQ); Reviewed: 15-Jul-2023, QC No. AJPBP-23-109519; Revised: 22-Jul-2023, Manuscript No. AJPBP-23-109519(R); Published: 29-Jul-2023
Description
Anticonvulsants, also known as Anti-Epileptic Drugs (AEDs), are a class of medications designed to control and prevent seizures in individuals suffering from epilepsy and other seizure disorders. Seizures are disruptive electrical activities in the brain that can lead to various physical and cognitive disturbances. The development and widespread use of anticonvulsants have revolutionized the management of epilepsy, improving the quality of life for millions worldwide. This article discusses about the history, mechanisms of action, and the importance of anticonvulsants in the treatment of seizures [1].
History of anticonvulsants
The history of anticonvulsants dates back to the late 19th century when bromides were first used to control seizures. However, these early medications had severe side effects, limiting their long-term use. It was not until the mid-20th century that the first-generation anticonvulsants, such as phenytoin and carbamazepine, were introduced. These drugs were more effective and better tolerated, leading to a significant improvement in seizure management. [2-4]
Mechanisms of action
Anticonvulsants act on various molecular targets in the brain to stabilize neural activity and prevent excessive electrical discharge. The precise mechanisms of individual drugs may vary, but their primary actions can be classified into several categories:
Sodium channel blockers: Drugs like phenytoin, carbamazepine, and lamotrigine work by blocking voltage-gated sodium channels, preventing the spread of abnormal electrical impulses in the brain.
GABA enhancers: Gamma-Amino-Butyric Acid (GABA) is a neurotransmitter that inhibits brain activity. Drugs such as benzodiazepines and valproic acid enhance GABA’s effects, reducing excessive electrical firing.
Calcium channel blockers: Ethosuximide and valproic acid act on calcium channels, reducing the influx of calcium into neurons and suppressing abnormal electrical activity.
Glutamate antagonists: Some anticonvulsants, like topiramate, target glutamate receptors, which are excitatory neurotransmitters. By reducing the effect of glutamate, they inhibit seizure propagation [5].
Importance in the treatment of seizures:
Seizure control: The primary goal of anticonvulsant therapy is to achieve seizure control. By reducing the frequency and intensity of seizures, these medications help individuals with epilepsy lead more stable and independent lives.
Epilepsy management: Anticonvulsants play a crucial role in the long-term management of epilepsy. In many cases, they allow patients to maintain seizure freedom and reduce the risk of seizure-related injuries and accidents.
Prevention of status epilepticus: Status epilepticus is a life-threatening condition characterized by continuous, prolonged seizures. Anticonvulsants are used in emergency settings to halt ongoing seizures and prevent the development of status epilepticus.
Improved q uality of life : By controlling seizures, anticonvulsants can improve an individual’s overall quality of life. They can minimize the disruptions caused by seizures, such as impairments in cognition, mood disturbances, and limitations in daily activities.
Challenges and considerations
Despite their significant benefits, anticonvulsant therapy also comes with challenges and considerations:
Side effects: Anticonvulsants may cause side effects ranging from mild to severe, including dizziness, fatigue, gastrointestinal disturbances, and mood changes. Finding the right medication and dosage for each patient is a delicate balancing act. [6, 7]
Individual variability: The response to anticonvulsants varies among individuals, making the selection of the most suitable drug a complex process. Some patients may require monotherapy, while others may need a combination of drugs.
Drug interactions: Anticonvulsants can interact with other medications, potentially reducing their efficacy or causing adverse effects. Healthcare providers must carefully manage drug combinations to avoid potential complications.
Anticonvulsants have revolutionized the treatment of seizures and epilepsy, providing hope and relief to millions of individuals worldwide. With their diverse mechanisms of action, these medications effectively control abnormal electrical activity in the brain and significantly improve the quality of life for those living with seizure disorders. However, careful consideration of individual variability and potential side effects is essential in selecting the most appropriate treatment. As research advances, the development of newer, more targeted anticonvulsants continues, promising further improvements in seizure management and ultimately enhancing the lives of those affected by epilepsy [8].
References
- Knights KM, Mangoni AA, Miners JO. Defining the COX inhibitor selectivity of NSAIDs: Implications for understanding toxicity. Expert Rev Clin Pharmacol 2010; 3(6):769-776.
- Merry AF, Gibbs RD, Edwards J, Ting GS, Frampton C, Davies E, et al. Combined acetaminophen and ibuprofen for pain relief after oral surgery in adults: A randomized controlled trial. Br J Anaesth 2010; 104(1):80-88.
- Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: Network meta-analysis. B C Med J 2011; 342.
- Bao F, John SM, Chen Y, Mathison RD, Weaver LC. The tripeptide phenylalanine-(D) glutamate-(D) glycine modulates leukocyte infiltration and oxidative damage in rat injured spinal cord. Neurosci 2006; 140(3):1011-1022.
- Mathison RD, Christie E, Davison JS. The tripeptide feG inhibits leukocyte adhesion. J Inflamm 2008; 5:6.
- Mathison R, Lo P, Tan D, Scott B, Davison JS. The tripeptide feG reduces endotoxin‐provoked perturbation of intestinal motility and inflammation. J Neurogastroenterol Motil 2001; 13(6):599-603.
- Fakhrudin N, Waltenberger B, Cabaravdic M, Atanasov AG, Malainer C, Schachner D, et al. Identification of plumericin as a potent new inhibitor of the NF‐κB pathway with anti‐inflammatory activity in vitro and in vivo. Br J Pharmacol 2014; 171(7):1676-1686.
- Warner-Schmidt JL, Vanover KE, Chen EY, Marshall JJ, Greengard P. Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proceedings of the National Academy of Sciences 2011; 108(22):9262-9267.
Copyright: © 2023 The Authors. This is an open access article under the terms of the Creative Commons Attribution Non Commercial Share A like 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/) This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.